Brooklyn Investment Group’s Takeda Pharmaceutical TAK Stock Holding History

Brooklyn Investment Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.24M	Buy	174,896 +88,691	+103%	+$1.56M	0.1%	162
2025 Q4	$1.36M	Buy	86,205 +59,054	+218%	+$844K	0.06%	256
2025 Q3	$410K	Sell	27,151 -971	-3%	-$14.4K	0.06%	330
2025 Q2	$435K	Buy	28,122 +15,946	+131%	+$236K	0.06%	328
2025 Q1	$181K	Buy	12,176 +10,947	+891%	+$153K	0.04%	370
2024 Q4	$16.3K	Buy	+1,229	New	+$16.9K	﹤0.01%	811

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Brooklyn Investment Group's TAK Position: Q1 2026 in Review

Brooklyn Investment Group increased its Takeda Pharmaceutical (TAK) stake by 103% in Q1 2026, buying an estimated $1.56M and bringing the position to 174,896 shares worth $3.24M. The position accounts for 0.1% of the portfolio, ranked #162.

Brooklyn Investment Group first reported a position in TAK in Q4 2024 and has held it in 6 quarters since. 361 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

Brooklyn Investment Group held 174,896 shares of Takeda Pharmaceutical worth $3.24M as of Q1 2026.
Brooklyn Investment Group bought 88,691 Takeda Pharmaceutical shares in Q1 2026, an estimated $1.56M.
Takeda Pharmaceutical made up 0.1% of Brooklyn Investment Group's portfolio in Q1 2026, its #162 holding.
Brooklyn Investment Group first reported a position in Takeda Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
361 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.